Sanger Sequencing Service Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

The Sanger sequencing service market size is projected to reach US$ 2,292.71 million by 2031 from US$ 841.62 million in 2023. The market is expected to register a CAGR of 13.3% during 2023–2031. Increasing number for Next-generation Sequencing and adoption of automation and robotics are likely to remain key trends in the market.

Sanger Sequencing Service Market Analysis

The sanger sequencing service market is driven by increasing research and development in genomics including genomic sequencing gene expression profiling, genetic variation analysis. Sanger sequencing remains a valued tool for validation of NGS data, targeted gene sequencing, and other specific genomics research applications. Additionally, increasing adoption of clinical diagnostics and personalized medicine is also expected to contribute to the market growth. Sanger sequencing plays an important role in clinical diagnostics for identifying genetic mutations associated with genetic disorders, cancer, and other disorders. Moreover, the surging adoption of personalized medicine and the need for precise genetic testing are contributing to the market growth. However, increasing use of sanger sequencing services in emerging economies is expected to create ample opportunities for the market growth in coming years.

Sanger Sequencing Service Market Overview

Sanger sequencing services market is expected to register the significant growth rate owing to the increase in research and development in genomics, clinical diagnostics, personalized medicine and others along with increasing number of service providers globally. Additionally, increasing use of sanger sequencing services in emerging economies is expected to create opportunities in coming years. The biomarkers and cancer application areas segment accounts for the largest market share owing to the surging incidence of cancer, increasing research on cancer biomarkers and increasing use of cancer biomarkers in drug discovery and diagnostics. Furthermore, In 2023, North America accounts for largest share in global Sanger sequencing service market and was projected to have highest market share over the forecast period. The growth of the Sanger sequencing service market in this region is primarily driven by the increasing cancer research, funding’s and developments for genomics and precision medicine. However, Asia Pacific is the fastest growing region owing to growing research activities and increasing presence of major market player are driving growth in the Asia Pacific region.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Sanger Sequencing Service Market: Strategic Insights

Sanger Sequencing Service Market

• 
  CAGR (2023 - 2031)

  13.3%
• Market Size 2023
  US$ 841.62 Million
• Market Size 2031
  US$ 2,292.71 Million

Market Dynamics

GROWTH DRIVERS

• Increase in research and development in genomics, clinical diagnostics, personalized medicine to propel the market growth

FUTURE TRENDS

• Increasing number of service providers globally contributing the market growth

OPPORTUNITIES

• Increasing use of sanger sequencing services in emerging economies for genetic testing

Key Players

• Microsynth AG
• Laragen Inc
• StarSEQ GmbH
• Thermo Fisher Scientific Inc
• LGC Biosearch Technologies
• Fasteris SA
• Quintara Biosciences
• GENEWIZ
• GenScript
• SciGenom Labs

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Application

• Diagnostics
• Biomarkers and Cancer
• Reproductive Health
• Personalized Medicine
• Forensics
• Other Applications

End User

• Academic and Government Research Institutes
• Biotechnology & Pharmaceutical Companies
• Hospitals and Clinics
• Other End Users

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Sanger Sequencing Service Market Drivers and Opportunities

Increasing Providers for Sanger Sequencing Services and Applications to Favor Market

Sanger sequencing service-providing companies are expanding their global reach to the market and also playing a significant role in increasing the adaptability of sequencing technologies across the globe. For instance, In June 2023, Source Genomics, a part of the Source BioScience group opened new laboratory in the North of England. This will provide Source Genomics industry-leading Sanger Sequencing service to the northern territory with faster turnaround times for optimized data delivery.

Moreover, in recent years, the CRISPR-Cas9 system has been established as the editing technique in complex organisms. This system is greatly considered as a choice due to advantages offered by it, such as cost-effectiveness, ease of use, and the high efficacy of desired targeted edits. However, in genome editing experiments, the repair process is not completely accurate; therefore, fragment analysis or Sanger sequencing by capillary electrophoresis (CE) are used to determine the efficiency of CRISPR-mediated genome editing in primary transformed cell cultures. Additionally, Sanger sequencing is also used to determine successful editing events in secondary clones. Thus, the growing usage of Sanger sequencing in different application will propel the Sanger sequencing service market.

Increasing Applications in Emerging Economies

The emerging markets in the developing countries in the Asia Pacific region are creating better opportunities for the major market players to expand their business. Most of the major players focus on emerging markets such as India, China, and others. As they have a large population and technological advancements in these countries also favor the growth of the market.

Furthermore, the growing healthcare sector in this region is likely to enhance the growth opportunities for the prenatal and newborn genetic testing market. For instance, the increasing number of corporate hospitals like Apollo group, Max, Fortis, and others in India is likely increasing professionalism as well as lead to the emergence of the latest medical technology. The Max Healthcare offers the prenatal test in India in order to identify as well as prevent the genetic disability in the newborn.

Thus, the growing population in emerging countries and advanced healthcare sector in the region is likely to boost the market and is expected to provide significant growth opportunities to the players operating in the market during the forecast period.

Sanger Sequencing Service Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Sanger sequencing service market analysis are application and end user.

• Based on application, the Sanger sequencing service market is segment into diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, others. The biomarkers and cancer segment held a largest market share in 2023.
• In terms of end user, the market is classified into academic and government research institutes, hospitals and clinics, biotechnology companies and pharmaceutical companies and others. The academic and government research institutes segment held a significant share of the market in 2023.

Sanger Sequencing Service Market Share Analysis by Geography

The geographic scope of the Sanger sequencing service market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the sanger sequencing service market and is estimated to have a larger share in the United States. The growth of the Sanger sequencing service market in the United States is expected to grow owing to rising applications of the Sanger sequencing. Molecular profiling of cancers is very crucial in personalized cancer therapy, or precision oncology. Sanger sequencing enables detection of low-level variant in the given sample with minimal amounts of DNA, such as formalin-fixed paraffin-embedded (FFPE) tissues. Thus, growing cancer prevalence in US is likely to demand for Sanger sequencing services. The National Cancer Institute estimated that in 2018, approximately 1,735,350 new cases of cancer will be diagnosed in the US. Furthermore, Sanger sequencing is used for confirming the sequence variants identified by Next Generation Sequencing. Thus, growing adoption of NGS in diagnostic laboratories and research institutes is likely to favor market growth.  Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Sanger Sequencing Service Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Sanger Sequencing Service Market News and Recent Developments

The Sanger sequencing service market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Sanger sequencing service market are listed below:

• Source Genomics, a part of Source BioScience group opened new laboratory in the North of England in June 2023. This will provide Source Genomics industry-leading Sanger Sequencing service to the northern territory with faster turnaround times for optimised data delivery. ( Source: Source BioScience, Company Website, 2023)
• Eurofins Genomics launched a revolutionary new, low-cost, whole plasmid sequencing service with same-day results. By leveraging Gen3 NGS (next generation sequencing) technology, this new service delivers a single-base accuracy of up to 99%. The new service, Whole Plasmid Sequencing, seeks to close the gap between Sanger and NGS by offering an affordable, fast solution for long-read sequencing. (Source: Eurofins Scientific, Company Website, 2023)
• Thermo Fisher Scientific launched its latest generation of SeqStudio Flex Series Genetic Analyzer to enable customers' cutting-edge research in areas such as gene editing and infectious disease. Capillary Electrophoresis (CE), which enables Sanger sequencing and fragment analysis is an important tool for improving clinical research and advancing scientific discovery. The SeqStudio Flex Genetic Analyzer delivers the gold-standard quality of CE technology with accurate data and reliable performance. (Source: Business Standard, Newsletter, 2022)

Sanger Sequencing Service Market Report Coverage and Deliverables

The “Sanger Sequencing Service Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Sanger sequencing service market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Sanger sequencing service market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Sanger sequencing service market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Sanger sequencing service market
• Detailed company profiles